Giving the Immune System a Hand
The immune system comprises a treasure trove of cell types with the potential to destroy cancer cells.
immuno-oncology
Penetrating Solid Tumors with CAR Immune Cells
LIVE October 13th, 2021 at 10:30 AM ET
Experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.
Experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.
Infographic: Immuno-oncology Drug Development Growth
Discover leading immunotherapy targets in the the drug development pipeline.
Bright Peak and Ajinomoto collaborate on immunocytokines
Bright Peak Therapeutics and Ajinomoto enter into research collaboration for novel immunocytokines
I-Mab launches immuno-oncology discovery initiative
New collaborations will give I-Mab access to cutting edge technology platforms for developing novel drug molecules
Introducing NGM438
NGM438 is an antagonist antibody that inhibits LAIR1
Exosomes to the rescue in cancer
Codiak demonstrates potential of engineered exosomes to stimulate targeted, antitumor immunity
